These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3870249)

  • 41. Plasma levels and urinary excretion of prostaglandins in patients with rheumatoid arthritis.
    Laitinen O; Seppalä E; Nissilä M; Vapaatalo H
    Clin Rheumatol; 1983 Dec; 2(4):401-6. PubMed ID: 6589104
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reference intervals and developmental changes in urinary prostanoid excretion in healthy newborns, infants and children.
    Leonhardt A; Busch C; Schweer H; Seyberth HW
    Acta Paediatr; 1992 Mar; 81(3):191-6. PubMed ID: 1511190
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Study of the effects of cicletanine on prostanoids.
    Guinot P; Frölich JC
    Arzneimittelforschung; 1985; 35(11):1714-6. PubMed ID: 3867354
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Altered renal and platelet arachidonic acid metabolism in cirrhosis.
    Laffi G; La Villa G; Pinzani M; Ciabattoni G; Patrignani P; Mannelli M; Cominelli F; Gentilini P
    Gastroenterology; 1986 Feb; 90(2):274-82. PubMed ID: 3079716
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Urinary excretion of prostaglandins during infancy and childhood: influence of age, sodium restriction and posture.
    Knoers N; Fiselier T; Thomas C; van den Berg R; Theeuwes A; Monnens L
    Prostaglandins Leukot Essent Fatty Acids; 1990 Apr; 39(4):295-301. PubMed ID: 2353030
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Metabolic mimicry of Bartter's syndrome by covert vomiting: utility of urinary chloride determinations.
    Veldhuis JD; Bardin CW; Demers LM
    Am J Med; 1979 Feb; 66(2):361-3. PubMed ID: 425977
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Measurement of prostaglandins in the cerebrospinal fluid in cat, dog, and man.
    Romero SD; Chyatte D; Byer DE; Romero JC; Yaksh TL
    J Neurochem; 1984 Dec; 43(6):1642-9. PubMed ID: 6593432
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased urinary NO2-/NO3- and cyclic guanosine monophosphate levels in patients with Bartter's syndrome: relationship to vascular reactivity.
    Caló L; D'Angelo A; Cantaro S; Bordin MC; Favaro S; Antonello A; Borsatti A
    Am J Kidney Dis; 1996 Jun; 27(6):784-9. PubMed ID: 8651241
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of intravenous administration of a calcium antagonist on prostaglandins and thromboxane in plasma and urine in humans.
    Honda M; Manabe R; Minato M; Watanabe M; Fukuda N; Izumi Y; Hatano M
    Prostaglandins Leukot Med; 1986 Aug; 23(2-3):289-302. PubMed ID: 3532135
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Low urinary calcium excretion in Bartter's syndrome.
    Rudin A; Sjögren B; Aurell M
    N Engl J Med; 1984 May; 310(18):1190. PubMed ID: 6709017
    [No Abstract]   [Full Text] [Related]  

  • 51. Contribution of urine volume to the elevated urinary prostaglandin E in Bartter's syndrome and central and nephrogenic diabetes insipidus.
    Fichman M; Zia P; Zipser R
    Adv Prostaglandin Thromboxane Res; 1980; 7():1193-7. PubMed ID: 7369030
    [TBL] [Abstract][Full Text] [Related]  

  • 52. PGE2, PGF2 alpha, 6-keto-PGF1 alpha, and TxB2 synthesis along the rabbit nephron.
    Farman N; Pradelles P; Bonvalet JP
    Am J Physiol; 1987 Jan; 252(1 Pt 2):F53-9. PubMed ID: 3101513
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prostaglandin E excretion and inhibition of prostaglandin synthesis in Bartter's syndrome.
    Hsieh BS; Chen WY; Yen TS; Lai MS
    Taiwan Yi Xue Hui Za Zhi; 1978 Nov; 77(11):831-8. PubMed ID: 284093
    [No Abstract]   [Full Text] [Related]  

  • 54. Full pattern of urinary prostaglandins in Bartter's syndrome.
    Calò L; Cantaro S; Piccoli A; Favaro S; Bonfante L; Borsatti A
    Nephron; 1990; 56(4):451-2. PubMed ID: 2080011
    [No Abstract]   [Full Text] [Related]  

  • 55. A case of pseudo-Bartter's syndrome due to intestinal malrotation.
    Koshida R; Sakazume S; Maruyama H; Okuda N; Ohama K; Asano S
    Acta Paediatr Jpn; 1994 Feb; 36(1):107-11. PubMed ID: 8165899
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Radioimmunoassay measurement of prostaglandins E2 and F2alpha in human urine.
    Ciabattoni G; Pugliese F; Spaldi M; Cinotti GA; Patrono C
    J Endocrinol Invest; 1979; 2(2):173-82. PubMed ID: 489926
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Indomethacin in Bartter's syndrome: does the syndrome represent a state of hyperprostaglandinism?
    Donker AJ; de Jong PE; van Eps LW; Brentjens JR; Bakker K; Doorenbos H
    Nephron; 1977; 19(4):200-13. PubMed ID: 917167
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Urinary kallikrein excretion in Bartter's syndrome.
    Lechi A; Covi G; Lechi C; Mantero F; Scuro LA
    J Clin Endocrinol Metab; 1976 Nov; 43(5):1175-8. PubMed ID: 993321
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Renal tubular reabsorption of chloride in Bartter's syndrome and other conditions with hypokalemia.
    Rodriguez Portales JA; Delea CS
    Clin Nephrol; 1986 Dec; 26(6):269-72. PubMed ID: 3802593
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dissociation of effects of xanthine analogs on renal prostaglandins and renal excretory function in the awake rat.
    Baer PG; Armstrong EL; Cagen LM
    J Pharmacol Exp Ther; 1983 Dec; 227(3):600-4. PubMed ID: 6581288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.